Volume 72, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


This paper reports a two-phase study in Bangui, Central African Republic (CAR): first, we assessed the clinical efficacy to chloroquine (CQ), sulfadoxine-pyrimethamine (SP), and amodiaquine (AQ), then we tested the efficacy of two combinations: CQ + SP and AQ + SP. We used the standard 14-day WHO 2001 protocol to compare therapeutic responses in children under 5 years of age with acute uncomplicated malaria in Bangui between February 2002 and March 2004. The overall treatment failure rates with CQ, AQ, SP, CQ + SP, and AQ + SP were 40.9%, 20.0%, 22.8%, 7.2%, and 0%. These findings suggest that the Ministry of Health should recommend an interim policy with AQ + SP combination as the first-line antimalarial drug in Bangui until best alternative treatments like artemisinin-based combination therapies (ACTs) become available at low prices in the CAR.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Bloland PB, Kazembe PN, Oloo AJ, Himonga B, Barat LM, Ruebush TK, 1998. Chloroquine in Africa: critical assessment and recommendations for monitoring and evaluating chloroquine therapy efficacy in sub-Saharan Africa. Trop Med Int Health 3 : 543–552. [Google Scholar]
  2. Basco LK, Same-Ekobo A, Foumane Ngane V, Ndounga M, Metoh T, Ringwald P, Soula G, 2002. Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria young children in Cameroon. Bull WHO 80 : 538–545. [Google Scholar]
  3. Nsimba B, Malonga DA, Mouata AM, Louya F, Kiori J, Malanda M, Yocka D, Oko-Ossho J, Ebata-Mongo S, Le Bras J, 2004. Efficacy of sulfadoxine/pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria in Republic of Congo. Am J Trop Med Hyg 70 : 133–138. [Google Scholar]
  4. Kazadi WM, Vong S, Makina BN, Mantshumba JC, Kabuya W, Kebela BI, Ngimbi NP, 2003. Assessing the efficacy of chloroquine and sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in the Democratic Republic of Congo. Trop Med Int Health 8 : 868–875. [Google Scholar]
  5. Mezui Me Ndong J, Atteke C, Aubouy A, Bakary M, Lébibi J, Deloron P, 2003. ln vitro activity of chloroquine, quinine, méfloquine and halofantrine against Gabonese isolates of Plasmodium falciparum. Trop Med Int Health 8 : 25–29. [Google Scholar]
  6. Pierce PF, Milhous WK, Campbell CC, 1987. Clinical and laboratory characterization of a chloroquine-resistant Plasmodium falciparum strain acquired in the Central African Republic. Am J Trop Med Hyg 36 : 1–2. [Google Scholar]
  7. Belec L, Delmont J, Vesters I, Testa J, Christian KS, Georges AJ, 1988. Emergence of multiresistant Plasmodium falciparum malaria in Central African Republic. Press Med 17 : 2090–2091. [Google Scholar]
  8. Debat Zoguereh D, Delmont J, Testa J, N’gama G, 1988. Etude de la chimiosensibilité de Plasmodium falciparum aux amino-4-quinoléines chez des enfants centrafricains. Med Afr Noire 35 : 101–104. [Google Scholar]
  9. Delmont J, Testa J, Monges P, Limbassa J, Georges AJ, Faugere B, 1987. Etat da la chimiorésistance de Plasmodium falciparum en République Centrafricaine. Résultats d’enquêtes menées de 1984 à 1986. Bull Soc Path Exot 80 : 434–442. [Google Scholar]
  10. Delmont J, Testa J, Courtois P, Capdevielle H, Le Tien C, Roungou JB, 1992. Persistence of low levels of Plasmodium falciparum resistance to chloroquine in the autochthonous population of the Central African Republic. J Hyg Epid Microb Immun 36 : 362–367. [Google Scholar]
  11. Desfontaines M, Cathebras P, Delmont J, Testa J, Bechan R, Somse P, Roungou JB, 1987. Surveillance de l’extension de la chloroquino-resistance de Plasmodium falciparum en Centrafrique. Bull Liais Doc OCEAC 82 : 45–47. [Google Scholar]
  12. Bergeri I, Debat Zoguereh D, Madji N, Barrau K, Delmont J, Namsenmo A, Ndoyo J, 2003. Evaluation in vivo de l’efficacité thérapeutique de la chloroquine pour le traitement du paludisme dû à Plasmodium falciparum non compliqué en Centrafrique en 1997 et 1998. Bull Soc Pathol Exot 96 : 29–34. [Google Scholar]
  13. Ringwald P, Keudjian A, Same Ekobo A, Basco LK, 2000. Chemoresistance of Plasmodium falciparum in the urban areas of Yaounde, Cameroon Part 2: Evaluation of the efficacy of amodiaquine and sulfadoxine-pyrimethamine combination in the treatment of uncomplicated Plasmodium falciparum malaria in Yaoundé, Cameroon. Trop Med Int Health 5 : 20–27. [Google Scholar]
  14. Nevill CG, Verhoeff FH, Munafu CG, ten Hove WR, van der Kaay HJ, Were JB, 1994. A comparison of amodiaquine and chloroquine in the treatment therapy of falciparum malaria in Kenya. East African Medical Journal 71 : 167–170. [Google Scholar]
  15. Müller O, van Hensbroek MB, Jaffar S, Drakely C, Okorie C, Joof D, 1996. A randomized trial of chloroquine, amodiaquine and pyrimethamine-sulphadoxine in Gambian children with uncomplicated malaria. Trop Med Int Health 1 : 124–132. [Google Scholar]
  16. Nwanyanwu OC, Ziba C, Kazembe P, Chitsulo L, Wirima JJ, Kumwenda N, 1996. Efficacy of sulphadoxine/pyrimethamine for Plasmodium falciparum malaria in Malawian children under five years of age. Trop Med Intl Health 1 : 231–235. [Google Scholar]
  17. Bloland PB, Lackritz EM, Kazembe PN, Were JB, Steketee R, Campbell CC, 1993. Beyond chloroquine implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. J Inf Dis 167 : 932–937. [Google Scholar]
  18. White N, 1999. Antimalarial drug resistance and combination chemotherapy. Philos Trans R Soc London B Biol Sci 354 : 739–749. [Google Scholar]
  19. Nosten F, van Vugt M, Price R, 2000. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet 356 : 297–302. [Google Scholar]
  20. White NJ, 1999. Delaying antimalarial drug resistance with combination chemotherapy. Parassitologia 41 : 301–308. [Google Scholar]
  21. Ministère du plan et de la coopération internationale, UNICEF, 2001. Enquête à indicateurs multiples, MICS 2000, Rapport final Bangui Avril 2001. BBA Editions, Bangui, Central African Republic. 130–131
  22. World Health Organization (WHO), 2001. Monitoring Antimalarial Drug Resistance. WHO/CDS/CSR/EPH/2002.7. Geneva: WHO.
  23. WHO/CTD, 1996. Assessment of Therapeutic Efficacy of Anti-malarial Drugs for Uncomplicated Malaria in Areas with Intense Transmission. WHO/MAL/96.1077. Geneva: WHO.
  24. Garcia-Vidal J, Ngirabega JD, Soldevila M, Navarro R, Bada JL, 1989. Evolution of resistance of Plasmodium falciparum to antimalarial drugs in Rwanda, 1985–1987. Trans R Soc Trop Med Hyg 83 : 490. [Google Scholar]
  25. Paluku KM, Breman JG, Moore M, Ngimbi NP, Sexton JD, 1988. Response of children with Plasmodium falciparum to chloroquine and development of an national malaria treatment policy in Zaire. Trans R Soc Trop Med Hyg 82 : 353–357. [Google Scholar]
  26. Mharahurwa S, Mugochi T, 1994. Chloroquine resistance falciparum malaria in an area of rising endemicity in Zimbabwe (1984–1993). J Trop Med Hyg 97 : 39–45. [Google Scholar]
  27. Checchi F, Balkan S, Vonhm BT, Massaquoi M, Biberson P, Eldin de Pecoulas P, Brasseur P, Guthmann JP, 2002. Efficacy of amodiaquine for uncomplicated Plasmodium falciparum malaria in Harper, Liberia. Trans R Soc Trop Med Hyg 96 : 670–673. [Google Scholar]
  28. Checchi F, Durand R, Balkan S, Vonhm BT, Kollie JZ, Biberson P, Baron E, Lebras J, Guthmann JP, 2002. High Plasmodium falciparum resistance to chloroquine and sulfadoxine-pyrimethamine in Harper, Liberia: results in vivo and analysis of point mutations. Trans R Soc Trop Med Hyg 96 : 664–669. [Google Scholar]
  29. Bijl HM, Kager J, Koetsier DW, Van der Werf TS, 2000. Chloroquine- and sulfadoxine-pyrimethamine-resistant falciparum malaria in vivo—a pilot study in rural Zambia. Trop Med Int Health 10 : 692–695. [Google Scholar]
  30. Staedke SG, Kamya MR, Dorsey G, 2001. Amodiaquine, sulfadoxine/pyrimethamine, and combination therapyfor treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial. Lancet 358 : 368–374. [Google Scholar]
  31. Gasasira AF, Dorsey G, Nzarubara B, Staedke SG, Nassali A, Rosenthal PJ, Kamya MR, 2003. Comparative efficacy of aminoquinoline-antifolate combinations for the treatment of uncomplicated falciparum malaria in Kampala, Uganda. Am J Trop Med Hyg 68 : 127–132. [Google Scholar]
  32. Schellenberg D, Kahigwa E, Drakeley C, Malende A, Wigayi J, Msokame C, Aponte JJ, Tanner M, Mshinda H, Menendez C, Alonso PL, 2002. The safety and efficacy of sulfadoxine-pyrimethamine, amodiaquinen and their combination in the treatment of uncomplicated Plasmodium falciparum malaria. Am J Trop Med Hyg 67 : 17–23. [Google Scholar]
  33. Watkins WM, Mberu EK, Winstanley PA, Plowe C, 1997. The efficacy of antifolates antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmaco-kinetic analyses. Parasitology Today 13 : 459–464. [Google Scholar]
  34. Duraisingh MT, Drakeley CJ, Muller O, Bailey R, Snounou G, Targett GA, Greenwood BM, Warhurst DC, 1997. Evidence for selection for the tyrosine-86 allele of the pfmdr 1 gene of Plasmodium falciparum by chloroquine and amodiaquine. Parasitology 114 : 205–211. [Google Scholar]
  35. Rwagacondo CE, Niyitegeka F, Sarushi J, Karema C, Mugisha V, Dujardin JC, Van Overmeir C, Ven Den Ende J, D’alessandro U, 2003. Efficacy of amodiaquine alone and combined with sulfadoxine-pyrimethamine and of sulfadoxine-pyrimethamine combined with artesunate. Am J Trop Med Hyg 68 : 743–747. [Google Scholar]
  36. Talisuna AO, Nalunkuma-Kazibwe A, Bakyaita N, Langi P, Mutabingwa TK, Watkins WW, Van Marck E, D’Alessandro U, Egwang TG, 2004. Efficacy of sulphadoxine-pyrimethamine alone or combined with amodiaquine or chloroquine for the treatment of uncomplicated falciparum malaria in Ugandan children. Trop Med Intl Health 9 : 222–229. [Google Scholar]
  37. Dorsey G, Njama D, Kamya UR, Cattamanchi A, Kyabayinze D, Staedke SG, Gasasira A, Rosenthal PJ, 2002. Short and long term efficacies for uncomplicated malaria of sulphadoxine/pyrimethamine alone or in combination with amodiaquine or artesunate: a longitudinal randomized trial in Ugandan children. Lancet 360 : 2031–2038. [Google Scholar]

Data & Media loading...

  • Received : 27 May 2004
  • Accepted : 02 Nov 2004

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error